http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104407151-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate | 2014-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104407151-B |
| titleOfInvention | Kindlin-2, Myosin-9 and Annexin II tri-albumen associated prediction patients with esophageal squamous cell carcinoma prognosis kit |
| abstract | The technical problem to be solved is to provide and a kind of detects the reagent of destination protein expression in paraffin-embedded tissue. This invention address that the technical scheme of this technical problem there is provided a kind of detection kit evaluating patients with esophageal squamous cell carcinoma prognosis information. Does this test kit include the antibody-Annexin of 3 kinds of destination proteins? II, Kindlin-2 and Myosin-9 antibody, also includes lowlenthal serum, 0.01M citrate repair liquid, 3%H 2 O 2 , Polymer reinforcing agent, Polymer polymer, DAB colour reagent, PBS solution. Use this test kit can evaluate the prognosis of patients with esophageal squamous cell carcinoma, by stages simple, more easy than international TNM, and sensitivity and specificity are all higher, and it is more suitable for the esophageal squamous cell carcinoma prognosis evaluation of compatriots. |
| priorityDate | 2014-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 77.